Acute Investment Advisory’s Vanguard Short-Term Treasury ETF VGSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-140,702
Closed -$8.12M 18
2023
Q2
$8.12M Buy
140,702
+11,681
+9% +$680K 4.88% 6
2023
Q1
$7.55M Sell
129,021
-148,591
-54% -$8.63M 4.95% 4
2022
Q4
$16.1M Sell
277,612
-84,380
-23% -$4.87M 10.94% 2
2022
Q3
$20.9M Buy
361,992
+95,829
+36% +$5.61M 15.02% 2
2022
Q2
$15.7M Buy
266,163
+27,620
+12% +$1.63M 12.18% 2
2022
Q1
$14.1M Buy
+238,543
New +$14.3M 10.55% 2

Other funds holding VGSH

Acute Investment Advisory's VGSH Position: Q3 2023 in Review

Acute Investment Advisory sold out of Vanguard Short-Term Treasury ETF (VGSH) in Q3 2023, closing a stake of 140,702 shares — an estimated $8.12M sold.

Acute Investment Advisory first reported a position in VGSH in Q1 2022 and held it in 6 quarters. The position peaked at $20.9M in Q3 2022. 809 funds tracked by Wall St. Rank hold VGSH as of Q3 2023.

  • Acute Investment Advisory reported no remaining Vanguard Short-Term Treasury ETF position as of Q3 2023 after selling out during the quarter.
  • Acute Investment Advisory sold 140,702 Vanguard Short-Term Treasury ETF shares in Q3 2023, an estimated $8.12M.
  • Acute Investment Advisory first reported a position in Vanguard Short-Term Treasury ETF in Q1 2022 and held it in 6 quarters.
  • Acute Investment Advisory's Vanguard Short-Term Treasury ETF position peaked at $20.9M in Q3 2022.
  • 809 funds tracked by Wall St. Rank held Vanguard Short-Term Treasury ETF as of Q3 2023.

Based on Acute Investment Advisory's 13F filing for Q3 2023, filed 24 Oct 2023.